JPRN-UMIN000037839招募中未知
A study of usefulness of plasma lyso-GL-3 as a biomarker in patients with Fabry disease - Plasma lyso-GL-3 in patients with Fabry disease
Osaka University Graduate School of Medicine, Division of Health Science, Child Healthcare and Genetic Science Laboratory0 个研究点目标入组 100 人开始时间: 2019年9月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients who received before, are receiving now or are scheduled to receive Hematopoietic Stem Cell Transplantation / Chaperone therapy. 2) Patients who are considered as ineligible for the study by the investigator.
研究者
相似试验
已完成
不适用
Evaluation of effectiveness of plasma lyso-Gb3 analogues as biomarker for diagnosing of Fabry diseaseFabry diseaseJPRN-UMIN000036465Department of Clinical Nephroscience, Niigata University Graduate School of Medical and Dental Sciences100
已完成
不适用
Validation study for lyso-Gb3 plasma concentration in healthy adult or child Japanese volunteersFabry diseaseJPRN-UMIN000016854Meiji Pharmaceutical University100
招募中
不适用
To investigate efficacy and safety of clozapine treatment for schizophrenia focusing on plasma clozapine concentrations and cytokine levels.Psychiatric disorderJPRN-UMIN000048075Kosekai-Kusatsu Hospital30
尚未招募
Unknown
Prospective Comparative Study use of plasmalyte vs volulyte as priming solution on cardiac bypass during cardiac surgeryCTRI/2024/08/071833Dr Manjula Sarkar
已完成
不适用
Retrospective study of lyso-Gb3 plasma concentration in Fabry patients receiving ERT/ReplagalFabry diseaseJPRN-UMIN000017152Meiji Pharmaceutical University100